KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non-Current Liabilities (2016 - 2025)

Teva Pharmaceutical Industries' Other Non-Current Liabilities history spans 17 years, with the latest figure at $3.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 5.46% year-over-year to $3.8 billion, compared with a TTM value of $3.8 billion through Dec 2025, down 5.46%, and an annual FY2025 reading of $3.8 billion, down 5.46% over the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $3.8 billion at Teva Pharmaceutical Industries, up from $3.7 billion in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $4.4 billion in Q2 2024, with the low at $2.2 billion in Q3 2021.
  • Average Other Non-Current Liabilities over 5 years is $3.6 billion, with a median of $3.9 billion recorded in 2022.
  • Year-over-year, Other Non-Current Liabilities soared 75.17% in 2022 and then dropped 15.65% in 2025.
  • Tracing TEVA's Other Non-Current Liabilities over 5 years: stood at $2.6 billion in 2021, then surged by 53.03% to $3.9 billion in 2022, then grew by 1.88% to $4.0 billion in 2023, then increased by 0.22% to $4.0 billion in 2024, then fell by 5.46% to $3.8 billion in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Other Non-Current Liabilities are $3.8 billion (Q4 2025), $3.7 billion (Q3 2025), and $3.9 billion (Q2 2025).